维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

16篇 您的检索式：作者名="FILIPPATOS T D"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Statin-associated adverse effects beyond muscle and liver toxicity显示文摘	Kiortsis D N Filippatos T D Mikhailidis D P	2007	Atherosclerosis2007，195，1：	1
	2	Altera- tion in the high density lipoprotein phenotype and HDL as- sociated enzymes in subjects with metabolic syndrome 显示文摘	Lagos K G Filippatos T D Tsimihodimos V	2009	Lipids2009，44，1：	1
	3	Increased plas- ma visfatin concentration is a marker of an atherogenic metabolic profile 显示文摘	Filippatos T D Tsimihodimos V Derdemezis C S	2013	Nutr Metab Cardiovasc Dis2013，23，4：	1
	4	Orlistat- associated adverse effects and drug interactions:a critical review 显示文摘	Filippatos T D Derdemezis C S Gazi I F	2008	Drug Safety2008，31，1：	1
	5	Effect of rosuv- astatin treatment on plasma visfatin levels in patients with primary hy- perlipidemia显示文摘	Kostapanos M S Derdemezis C S Filippatos T D	2008	Eur J Pharmaco12008，578，23：	1
	6	Vasopressin and vas-opressin antagonists in heart failure and hyponatremia显示文摘	Farmakis D Filippatos G Kremastinos D T	2008	Curr HeartFail Rep2008，5，2：	1
	7	Increased plasma visfatin levels in subjects with the metabolic syndrome显示文摘	FILIPPATOS T D DERDEMEZIS C S GAZI I F	2008	Eur J Clin Invest2008，38，1：	1
	8	Visfatin/PBEF and atheroselerosis'-related diseases 显示文摘	Filippatos T D Randeva H S Derdemezis C S	2010	Curt Vase Pharmacol2010，8，1：	1
	9	Review article:effects of plant sterols and stanols beyond lowdensity lipoprotein cholesterol lowering显示文摘	DERDEMEZIS C S FILIPPATOS T D MIKHAILIDIS D P	2010	Journal of Cardiovascular Pharmacology and Therapeutics2010，15，2：	1
	10	Orlistat-associated adverse effects and drug interactions:a critical review显示文摘	Filippatos T D Derdemezis C S Gazi I F	2008	Drug Safety2008，31，1：	1
	11	Effect of Rosuvastatin Treatment on Plasma Vislatin Levels in Patients with Primary Hyperlipidemia 显示文摘	KOSTAPANOS M S DERDEMEZIS C S FILIPPATOS T D	2008	Eur J Pharmacol2008，578，23：	1
	12	Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome 显示文摘	FILIPPATOS T D DERDEMEZIS C S KIORTSIS D N	2007	J Endocrinol Invest2007，30，4：	1
	13	Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia显示文摘	Filippatos T D Elisaf M S	2011	Expert Opin Pharmacother2011，12，12：	1
	14	Visfatin/PBEF and atherosclerosis-related diseases 显示文摘	Filippatos T D Randeva H S Derdemezis C S	2010	Curt Vasc Pharmacol2010，8，1：	1
	15	Visfatin/PBEF and atherosclerosis-related diseases 显示文摘	FILIPPATOS T D RANDEVA H S DERDEMEZIS C S	2010	Curt Vasc Pharmacol2010，8，1：	1
	16	Effects of sibutramine and orlistat on mood in obese and overweight subjects: A randomised Study显示文摘	Kiortsis D N Tsouli S b Filippatos T D	2008	Nutrition Metabolism & Cardiovascu lar Diseases2008，18，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费